Ansell to showcase hand protection solutions
Dubai, January 23, 2013
Ansell, a global leader in protection solutions, will showcase various innovative products in hand protection for healthcare professionals at Arab Health 2013, the largest healthcare exhibition in the Middle East.
Arab Health 2013 is running from January 28 to 31 at Dubai International Convention and Exhibition Centre.
“Ansell has a long tradition of taking part in the Arab Health fair,” said Peter Dobbelsteijn, senior vice president and regional director EMEA, Ansell.
“Once more, healthcare workers may discover the latest Ansell innovations and take part in the on-going discussion about safety and health issues related to glove use.”
The Gammex non-latex accelerator-free sensitive glove with Sensoprene is 30 per cent thinner than standard synthetic surgical gloves and delivers an unprecedented level of sensitivity combined with strength, resistance and advanced allergy protection, he added.
The Gammex powder-free glove with AMT antimicrobial technology is the first solution to protect surgical staff against microbial transmission due to intraoperative glove breaches. Both technologies are proof points of the ongoing commitment of Ansell to develop clinically relevant products in anticipation of healthcare workers’ needs.
Gammex gloves combine superior sensitivity, glove strength and grip with type I and IV allergy prevention.
Allergic reactions to latex proteins (type I allergies) and chemical accelerators (type IV allergies) in gloves are a key issue among healthcare workers. While type I allergies make up 17 per cent of glove-related reactions, 33 per cent are chemical allergies.
This is a result of a skin hypersensitivity called contact dermatitis from regular exposure to chemicals used in glove manufacturing. Often, healthcare workers who use gloves that are latex- and accelerator-free have to make compromises in glove thickness and thus sensitivity. Ansell has solved this issue providing unparalleled strength, resistance, grip and allergy protection, a company statement said.
Gammex is the first surgical glove to incorporate its own immune system to further protect surgical healthcare workers against viruses and bacteria in the event of a breach during surgery.
One in three gloves are perforated during surgical procedures, potentially exposing healthcare providers to pathogens such as HIV or hepatitis C and drug-resistant bacteria, the statement said.
The gloves kill more than 99 per cent of a hepatitis C virus surrogate as early as one minute following exposure and 99 per cent of HIV-1 strain Mn2 as early as one minute following exposure (clinical and laboratory tests).
Gammex acts like a second skin, with its own immune system to further protect surgical teams against harmful pathogens, according to the statement. – TradeArabia News Service
More Health & Environment Stories
- University of Ain Shams opens MS treatment unit
- Bahrain's humidity could ease water crisis
- Visibility in Bahrain forecast to improve
- Bahrain-India venture plans hospitals in GCC
- Seha launches new health initiative
- Veolia backs Oman waste management meet
- Obesity rate at 72pc among Saudi adults
- Bahrain ideal for artificial rain experiment
- Riyadh 'among most polluted cities'
- CGM acquires 3 European healthcare IT providers
- The age of genomic medicine dawns, finally
- Over 300 exhibitors for Saudi healthcare event
- Mackeen unveils document management solution
- Seha opens new clinics in Abu Dhabi, Al Ain
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth